Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Short Interest Down 30.8% in September

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPFGet Free Report) was the target of a significant decrease in short interest in the month of September. As of September 15th, there was short interest totalling 15,500 shares, a decrease of 30.8% from the August 31st total of 22,400 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Towa Pharmaceutical Price Performance

TWAPF opened at $24.35 on Friday. The company has a fifty day moving average price of $24.35 and a two-hundred day moving average price of $24.35. Towa Pharmaceutical has a 52 week low of $24.35 and a 52 week high of $24.35.

Towa Pharmaceutical Company Profile

(Get Free Report)

Towa Pharmaceutical Co, Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products.

Featured Articles

Receive News & Ratings for Towa Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Towa Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.